Incremin Syrup Philippines - English - FDA (Food And Drug Administration)

incremin syrup

glaxosmithkline philippines, inc. - vitamin b-complex , lysine , iron - syrup - each 5ml contains; thiamine hydrochloride (vitamin b1) - 10mg pyridoxine hydrochloride (vitamin b6)-5mg cyanocobalamin (vitamin b12)-25mcg l-lysine hydrochloride-300mg iron(as ferric pyrophospate soluble) - 30mg (equivalent to 250mg ferric pyrophosphate soluble) - l-lysine hcl and ferric pyrophosphate (equivalent to elemental iron). it also includes b-complex vitamins such as b 1 , b 6 and b 12 . this product also contains alcohol 0.95% v/v subcomponent. - this product is indicated for the treatment and prevention of vitamin b complex deficiency and iron deficiency anemia (ida).

ESCAVITE LQ- vitamin a palmitate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, d-, thiamine hydrochloride, ribofl United States - English - NLM (National Library of Medicine)

escavite lq- vitamin a palmitate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, d-, thiamine hydrochloride, ribofl

gm pharmaceuticals, inc - vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, d- (unii: a7e6112e4n) (.alpha.-tocopherol, d- - unii:n9pr3490h9), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), pyridoxine hydro - vitamin a 1500 [iu] in 1 ml - supplementation of the diet with nine essential vitamins and iron, and supplementation of the diet with fluoride for caries prophylaxis. the american academy of pediatrics recommends that children up to age 16, in areas where drinking water contains less than optimal levels of fluoride, receive daily fluoride supplementation.2 escavite® lq multi-vitamin with iron and fluoride 0.25 mg provides fluoride in drop form for infants and young children from 6 months to 3 years of age in areas where the drinking water contains less than 0.3 ppm of fluoride and for children ages 3-6 years in areas where the drinking water contains 0.3 through 0.6 ppm of fluoride.2,3 each 1.0 ml supplies sodium fluoride (0.25 mg fluoride per 1 ml) plus nine essential vitamins and iron. escavite® lq multi-vitamin with iron and fluoride 0.25 mg supplies significant amounts of vitamins a,c,d,e, thiamin, riboflavin, niacin, vitamin b6, vitamin b12, and iron to supplement the diet, and to help assure the deficiencies of these nutrients will

INJECTAFER- ferric carboxymaltose injection injection, solution
INJECTAFER- ferric carboxymaltose injection, solution United States - English - NLM (National Library of Medicine)

injectafer- ferric carboxymaltose injection injection, solution injectafer- ferric carboxymaltose injection, solution

american regent, inc. - ferric carboxymaltose (unii: 6897gxd6oe) (ferric cation - unii:91o4lml611) - ferric cation 50 mg in 1 ml - injectafer is indicated for the treatment of: •     iron deficiency anemia (ida) in: - adult and pediatric patients 1 year of age and older who have either intolerance or an unsatisfactory response to oral iron. adult and pediatric patients 1 year of age and older who have either intolerance or an unsatisfactory response to oral iron. - adult patients who have non-dialysis dependent chronic kidney disease. adult patients who have non-dialysis dependent chronic kidney disease. •     iron deficiency in adult patients with heart failure and new york heart association class ii/iii to improve exercise capacity. injectafer is contraindicated in patients with a history of hypersensitivity to injectafer or any of its components [see warnings and precautions (5.1) ]. risk summary parenteral iron administration may be associated with hypersensitivity reactions [ see warnings and precautions (5.1)], which may have serious consequences, such as fetal bradycardia (see clinical considerations ). advise pregnant wome

MEFENAMIC ACID- mefenamic acid capsule United States - English - NLM (National Library of Medicine)

mefenamic acid- mefenamic acid capsule

breckenridge pharmaceutical, inc. - mefenamic acid (unii: 367589pj2c) (mefenamic acid - unii:367589pj2c) - mefenamic acid 250 mg - carefully consider the potential benefits and risks of mefenamic acid and other treatment options before deciding to use mefenamic acid. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings; gastrointestinal bleeding, ulceration, and perforation ). mefenamic acid is indicated: - for relief of mild to moderate pain in patients ≥ 14 years of age, when therapy will not exceed one week (7 days). - for treatment of primary dysmenorrhea. mefenamic acid is contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to mefenamic acid or any components of the drug product (see warnings; anaphylactic reactions, serious skin reactions) . - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients (see warnings; anaphylactic reaction, exacerbation of asth

Fercobsang Solution Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fercobsang solution

gladron chemicals sdn bhd - cyanocobalamin; ferric ammonium citrate; nicotinamide/vitamin b3; cobalt gluconate -

Venufer 41mg (235 mg Ferric Ammonium   71.5mg/50 mcg per 5 mL) Syrup Philippines - English - FDA (Food And Drug Administration)

venufer 41mg (235 mg ferric ammonium 71.5mg/50 mcg per 5 ml) syrup

bliss pharma distribution and consultancy corp.; distributor: bliss pharma distribution and consultancy corp. - iron , folic acid , cyanocobalamin - syrup - 41mg (235 mg ferric ammonium 71.5mg/50 mcg per 5 ml)

Ferric carboxymaltose 50 mg iron/ml solution for injection/infusion Ireland - English - HPRA (Health Products Regulatory Authority)

ferric carboxymaltose 50 mg iron/ml solution for injection/infusion

rowex ltd - ferric carboxymaltose - solution for injection/infusion - iron, parenteral preparations

Monoferric 100 mg/ml inj./inf. sol. i.v. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

monoferric 100 mg/ml inj./inf. sol. i.v. amp.

pharmacosmos a.s. - ferric derisomaltose 417 mg/ml - eq. iron 100 mg/ml - solution for injection/infusion - 100 mg/ml - ferric derisomaltose 417 mg/ml - iron, parenteral preparations

Monoferric 100 mg/ml inj./inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

monoferric 100 mg/ml inj./inf. sol. i.v. vial

pharmacosmos a.s. - ferric derisomaltose 417 mg/ml - eq. iron 100 mg/ml - solution for injection/infusion - 100 mg/ml - ferric derisomaltose 417 mg/ml - iron, parenteral preparations

Monoferric 100 mg/ml inj./inf. sol. i.v. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

monoferric 100 mg/ml inj./inf. sol. i.v. amp.

pharmacosmos a.s. - ferric derisomaltose 417 mg/ml - eq. iron 100 mg/ml - solution for injection/infusion - 100 mg/ml - ferric derisomaltose 417 mg/ml - iron, parenteral preparations